EXPERIMENTAL AND MOLECULAR PATHOLOGY

Scope & Guideline

Exploring the depths of disease mechanisms.

Introduction

Delve into the academic richness of EXPERIMENTAL AND MOLECULAR PATHOLOGY with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0014-4800
PublisherACADEMIC PRESS INC ELSEVIER SCIENCE
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1962 to 1995, from 1997 to 2024
AbbreviationEXP MOL PATHOL / Exp. Mol. Pathol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address525 B ST, STE 1900, SAN DIEGO, CA 92101-4495

Aims and Scopes

The journal 'EXPERIMENTAL AND MOLECULAR PATHOLOGY' focuses on the intersection of experimental and clinical research in molecular pathology. It aims to disseminate significant findings that enhance the understanding of disease mechanisms and improve diagnostic and therapeutic strategies.
  1. Molecular Mechanisms of Disease:
    Research exploring the molecular basis of various diseases, including cancer, autoimmune disorders, and cardiovascular diseases, often utilizing advanced molecular techniques.
  2. Pathological Processes and Biomarkers:
    Studies focused on identifying and validating biomarkers for disease progression, diagnosis, and prognosis, employing both in vitro and in vivo methodologies.
  3. Therapeutic Innovations:
    Investigations into novel therapeutic approaches, including drug development, gene therapy, and the application of nanomedicine in treating various diseases.
  4. Immunopathology:
    Research into the immune responses associated with diseases, including the role of immune cells and pathways in cancer and inflammatory conditions.
  5. Experimental Models in Pathology:
    Utilization of various experimental models, including animal models and cell cultures, to study disease mechanisms and test therapeutic interventions.
The journal has experienced a shift towards several trending and emerging themes that reflect the current interests and advancements in the field of molecular pathology.
  1. Cancer Genomics and Personalized Medicine:
    An increasing number of studies are focusing on the genomic characterization of tumors, aiming to develop personalized treatment strategies based on individual genetic profiles.
  2. Role of Non-Coding RNAs in Cancer:
    Research on the functions and mechanisms of non-coding RNAs, such as lncRNAs and miRNAs, is gaining traction, particularly in relation to cancer biology and therapeutics.
  3. Immunotherapy and Cancer Immunology:
    There is a growing emphasis on the role of the immune system in cancer treatment, with studies investigating novel immunotherapeutic approaches and the underlying immunological mechanisms.
  4. Microbiome and Disease Correlation:
    Emerging research is exploring the relationship between the microbiome and various diseases, highlighting its influence on disease progression and treatment responses.
  5. Technological Advancements in Molecular Pathology:
    Innovations in high-throughput sequencing, imaging techniques, and bioinformatics are increasingly featured in studies, emphasizing their role in advancing molecular pathology research.

Declining or Waning

While the journal maintains a broad focus on various aspects of molecular pathology, certain themes have seen a decline in recent publications. This shift may reflect evolving research priorities or advancements in technology.
  1. Traditional Histopathology Techniques:
    The reliance on conventional histological methods has decreased as molecular techniques become more prevalent, leading to fewer studies focused solely on traditional histopathology.
  2. Single Disease Focus Studies:
    There has been a noticeable decline in studies that focus exclusively on a single disease without considering broader implications or comparative analyses across diseases.
  3. Basic Science without Clinical Application:
    Research that does not bridge basic science with clinical applications appears to be diminishing, reflecting a trend towards more translational research that directly impacts patient care.
  4. Invasive Diagnostic Methods:
    As non-invasive and less invasive techniques gain prominence, studies relying heavily on invasive methods for diagnosis and treatment assessment are becoming less common.

Similar Journals

BIOLOGICAL PROCEDURES ONLINE

Advancing Biological Research, One Procedure at a Time.
Publisher: BMCISSN: Frequency: 1 issue/year

BIOLOGICAL PROCEDURES ONLINE is a premier open-access journal published by BMC, dedicated to advancing the fields of biochemistry, genetics, and molecular biology. With its electronic ISSN 1480-9222 and a strong commitment to accessibility since 2009, this journal provides a vital platform for researchers and scholars to disseminate their findings and foster collaboration within the scientific community. Based in the United Kingdom, this journal has garnered an impressive reputation, achieving Q1 status in the 2023 category rankings, with notable inclusion in the Scopus rankings, placing it in the 86th percentile among 221 peer journals in the general biochemistry, genetics, and molecular biology domain. It covers a broad range of topics, ensuring coverage of the latest advancements and methodologies in biological procedures, making it an essential resource for academics, practitioners, and students alike. Researchers are encouraged to submit their innovative work and contribute to the ongoing dialogue in this dynamic and ever-evolving field.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Decoding Disease at the Molecular Level
Publisher: ELSEVIERISSN: 0925-4439Frequency: 12 issues/year

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.

ACTA NEUROBIOLOGIAE EXPERIMENTALIS

Fostering Knowledge in Neurobiological Phenomena
Publisher: NENCKI INST EXPERIMENTAL BIOLOGYISSN: 0065-1400Frequency: 4 issues/year

ACTA NEUROBIOLOGIAE EXPERIMENTALIS, an esteemed journal published by the Nencki Institute of Experimental Biology in Poland, has been a pivotal platform for the dissemination of research in the fields of medicine and neuroscience since its inception in 1970. With an ISSN of 0065-1400 and an E-ISSN of 1689-0035, this journal has consistently aimed to contribute to the understanding of neurobiological phenomena, cementing its status within the academic community. Despite its current categorization in the Q3 and Q4 quartiles for Medicine and Neuroscience respectively, ACTA NEUROBIOLOGIAE EXPERIMENTALIS continues to uphold rigorous scientific standards, providing an invaluable resource for researchers, professionals, and students alike. As an essential scholarly outlet, it encourages the exploration of groundbreaking findings and clinical applications in neurobiology, making it an attractive choice for those eager to advance their understanding of this intricate field.

PATHOLOGY RESEARCH AND PRACTICE

Advancing the Frontiers of Pathological Science
Publisher: ELSEVIER GMBHISSN: 0344-0338Frequency: 12 issues/year

PATHOLOGY RESEARCH AND PRACTICE is a premier journal in the field of pathology and forensic medicine, published by Elsevier GmbH in Germany. With a rich publication history since 1978 and an impressive convergence period extending to 2024, this journal serves as a vital resource for researchers and professionals dedicated to advancing the understanding of pathological processes. It holds notable rankings, including Q3 in Cell Biology and Q2 in Pathology and Forensic Medicine for 2023, reflecting its significance in the academic community. The journal aims to publish innovative research findings, reviews, and case studies, facilitating a deeper understanding of disease mechanisms and improving diagnostic practices. Authors and readers alike benefit from its reputable platform, noted for its challenging and rigorous peer-review process. By fostering a collaborative environment and providing open access options, PATHOLOGY RESEARCH AND PRACTICE continues to contribute meaningfully to the discourse within its respective fields, thereby appealing to a diverse audience of researchers, professionals, and students.

ACTA NEUROPATHOLOGICA

Transforming Understanding of Neurological Disorders
Publisher: SPRINGERISSN: 0001-6322Frequency: 12 issues/year

ACTA NEUROPATHOLOGICA, published by Springer, is a leading journal in the fields of cellular and molecular neuroscience, clinical neurology, and pathology, recognized for its exceptional quality and impactful research. With an impressive impact factor and currently ranked in the Q1 tier across multiple categories in 2023, this journal serves as a premier platform for the dissemination of groundbreaking findings in neuropathology. The journal's robust Scopus rankings highlight its influence, standing at #2 in Pathology and Forensic Medicine and #5 in Clinical Neurology. Since its inception in 1961, ACTA NEUROPATHOLOGICA has provided crucial insights into neurological diseases and disorders, contributing significantly to the advancement of medical science. Aimed at researchers, practitioners, and students alike, this journal fosters a deeper understanding of neurological conditions and encourages innovative approaches within the field. It is essential reading for anyone dedicated to unraveling the complexities of the nervous system.

Human Gene

Pioneering Research in Genetics and Health
Publisher: ELSEVIERISSN: 2773-0441Frequency: 4 issues/year

Human Gene is an innovative open access journal published by ELSEVIER, dedicated to the ever-evolving field of genetics. Established in 2022, this journal serves as a vital resource for researchers, professionals, and students alike, aiming to facilitate the dissemination of groundbreaking research and advancements in both basic and clinical genetics. With an ISSN of 2773-0441, Human Gene focuses on providing a platform for high-quality studies that investigate genetic mechanisms, their implications in health and disease, and novel therapeutic strategies. The journal currently holds a Q4 ranking in both Genetics and Clinical Genetics categories, reflecting its emerging status within the scientific community, and strives to enhance its impact to better serve an engaged audience. With its base in Amsterdam, Netherlands, Human Gene is committed to making research accessible through its open access model, inviting contributions that advance our understanding of human genetics and foster collaboration across disciplines.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Elevating the Discourse in Pathology and Neuroscience
Publisher: WILEYISSN: 0305-1846Frequency: 7 issues/year

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY is a premier journal dedicated to advancing the understanding of the intricate relationships between pathology and neurobiology. Published by Wiley since 1975, this journal has established itself as a crucial resource for researchers, clinicians, and students interested in the latest insights and developments in the fields of pathology, neurology, and neuroscience. With an impressive history of convergence extending to 2024, it boasts a Q1 ranking in multiple categories including Histology, Neurology, and Pathology, reflecting its high impact and reputation in the academic community. Additionally, it ranks 18th out of 208 in Pathology and Forensic Medicine with a remarkable 91st percentile, signifying its relevance and influence in medical research. While not open access, this journal provides valuable content that contributes significantly to the ongoing discourse in neurobiological advancements and is a vital reference for those engaged in this dynamic field.

MOLECULAR ASPECTS OF MEDICINE

Advancing the Frontiers of Molecular Medicine
Publisher: ELSEVIERISSN: 0098-2997Frequency: 6 issues/year

MOLECULAR ASPECTS OF MEDICINE is a premier journal published by Elsevier, focusing on groundbreaking research in the fields of biochemistry, molecular biology, and medicine. With an impressive impact factor and ranking within the top quartile across multiple categories, including Q1 in Biochemistry, Clinical Biochemistry, and Molecular Medicine, it serves as an essential platform for sharing innovative findings that advance our understanding of molecular mechanisms in health and disease. The journal, which has been in publication since 1976, provides a diverse range of articles, addressing both fundamental and applied aspects of molecular medicine, thus appealing to a broad audience of researchers, professionals, and students. While MOLECULAR ASPECTS OF MEDICINE does not currently offer Open Access options, it remains a vital resource for accessing high-quality, peer-reviewed scholarly works that significantly contribute to the advancement of biomedical research.

Analytical Cellular Pathology

Empowering Scholars with Open Access Discoveries
Publisher: HINDAWI LTDISSN: 2210-7177Frequency:

Analytical Cellular Pathology, published by Hindawi Ltd, is a leading journal in the disciplines of Cancer Research, Cell Biology, and Pathology, and has been dedicated to advancing the field through open access since 1997. Based in Egypt, this journal plays a crucial role in disseminating cutting-edge research and innovative findings, fostering collaboration among researchers and professionals alike. With an impressive array of metrics, including its Q2 ranking in Pathology and Forensic Medicine and notable Scopus rankings, the journal attracts a diverse readership, ensuring significant impact in its categories. Designed to cater to the needs of both emerging and established scholars, Analytical Cellular Pathology promotes accessibility and exchange of knowledge, making it an indispensable resource for those engaged in modern cellular pathology research.

International Journal of Clinical and Experimental Pathology

Advancing Knowledge in Pathology and Beyond
Publisher: E-CENTURY PUBLISHING CORPISSN: 1936-2625Frequency: 12 issues/year

International Journal of Clinical and Experimental Pathology, published by E-CENTURY PUBLISHING CORP, serves as a vital resource for professionals in the field of pathology. With its ISSN 1936-2625, the journal has positioned itself within the competitive landscape of medical journals, achieving commendable rankings in Scopus, particularly in the categories of Pathology and Forensic Medicine (Rank #98/185) and Histology (Rank #38/58). Although its coverage in Scopus has been discontinued, the journal’s past contributions from 2009 to 2017 continue to be a touchstone for researchers interested in advancing their understanding of clinical and experimental pathology. The open-access format ensures accessibility to a wide audience, fostering collaboration and education in this essential medical discipline. By bridging clinical research and experimental findings, this journal plays a crucial role in disseminating knowledge and enhancing practices within pathology, making it an indispensable tool for researchers, professionals, and students alike.